Myasthenia gravis: Clinical evaluation of 153 patients;Miastenia grave: Avaliação clínica de 153 pacientes

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 B, 1999, Pages 457-464

  Cunha, Francisco Marcos B ^a,b   Scola, Rosana Hermínia ^a   Werneck, Lineu César ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical evaluation; Myasthenia gravis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES;

EID: 0033146128     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000300018     Document Type: Article

References (44)

1. Assis JL. Aspectos clínicos. In Assis JL (cd) Miastenia grave. São Paulo: Sarvier; 1990:7-36.
2. Drachman DR. Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
3. Engel AG. Acquired autoimmune myasthenia gravis. In Engel AG, Franzini-Armstrong, C (ed) Myology: basic and clinical. New York: McGraw, Hill, 1994;1769-1797.
4. Hopkins LC. Clinical features of myasthenia gravis. Neurol Clin 1994; 12:243-261.
5. Kaminski HJ, Maa E, Spiegel P, Ruff RL. Why are eye muscles frequently involved in myasthenia gravis? Neurology 1990;40:1663-1669.
6. Linton DM, Philcox D. Myasthenia gravis. Dis Mon 1990;11:597-637.
7. Lisak RP, Barchi RL Myasthenia gravis. Philadelphia: Saunders; 1982:5-36.
8. Oosterhuis HJGV. Myasthenia gravis. Edinburgh: Churchill Livingstone: 1984:21-50.
9. Osserman KR, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
10. Rowland LP. Myasthenia gravis. In Goldensohn ES, Appel SH (eds). Scientific approaches to clinical neurology. Philadelphia: Lea & Febiger; 1977:1518-1554.
11. Simpson JA. Myasthenia gravis. Practioner 1982;226:1045-1050
12. Werneck LC, Teive HAG. Miastenia grave: avaliação clínica e terapêutica de 55 casos Arq Neuropsiquiatr 1987;45:379-390.
13. Andrews PI, Massey JM, Howard JR, JF, Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994;44:1208-1214.
14. Barlow JL. Neonatal myasthenia gravis. Am J Dis Child 1981; 135:209-216.
15. Engel AG. Congenital Myasthenic Syndrome. Neurol Clin 1994;12:401-437.
16. LisaK RP. The clinical limits of myasthenia gravis and differential diagnosis. Neurology 1997; 48 Suppl 5:S36-S39
17. Marchiori PE. Identificação e significado de elementos imunológicos e morfológicos na miastenia grave: valor diagnóstico para o timoma Tese., Faculdade de Medicina-Universidade de São Paulo, São Paulo 1987.
18. Namba T, Brunner NG, Brown SB, Muguruma M, Grob D. Familial myasthenia gravis: report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol 1971;25:49-60
19. Seybold ME, Lindstrom JM. Myasthenia gravis in infancy. Neurology 1981;31:476-480.
20. Simpson JA. Myasthenia gravis: a new hypothesis. Scott Med J 1960;5:419-436.
21. Christenswn JL, Jensen TS, Tsiropoulos I, Sorensen T, Kjaer M, Hojer-Pedersen E, et al. Incidence and prevalence of myathenia gravis in Western Denmark: 1975 to 1989. Neurology 1993;43:1779-1783.
22. D'Alessandro R, Granieri E, Benassi G, Tola MR, Casmiro M, Mazzanti B, et al. Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara. Italy. Acta Neurol Scand 1991;83:83-88.
23. Gigheddu M, Puggioni G, Sanna G, Tamburini G, Murrosu F, Rachele ME, et al. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989;79:326-333.
24. Phillips LH II, Torner JC, Anderson MS, et al. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992;42:1888-1893.
25. Phillips LH II. The epidemiology of myasthenia gravis. Neurol Clin 1994:12:263-271.
26. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey. Arch Neurol 1991;48:733-739.
27. Donaldson DH, Asher M, Horan S, Rutherford RB, Ringel SP. The relationship of age to outcome in myasthenia gravis. Neurology 1990;40:786-790.
28. Kaminski HJ, Fenstermaker RA, Abdul-Karrim FW, Clayman J, Ruff RL. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 1993;16:1332-1337.
29. Lindstrom J, Shelton D, Fujii I. Myasthenia gravis. Adv Immunol 1988;42:233-284.
30. Maselli RA, Richman DP, Wollmann RL. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology 1991;41:1497-1504.
31. Newson-Davis J, Vincent AC, Wilcox HNA. Autoimmune disorders of the myoneuromuscular junction. In Lachmann PJ, Peters K, Rosen FS, Walport MJ (eds). Clinical aspects of immunology. Boston: Blackwell, 1993:2091-2111
32. Patrick J, Lindstrom JM. Autoimmune response to acetylcholine receptor. Science 1973:180:871-882.
33. Richman DP, Agius MA. Acquired myasthenia gravis: Immunopathology. Neurol Clin 1994; 12:273-284.
34. Nastuk NL, Plescia O, Osserman KE. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med 1960;105:177-184.
35. Strauss AJL, Seegal BC, Hsu KC, Burkhol-Der PM, Nastyk, WC, Osserman KE. Immunofluoresccnce demonstration of a muscle binding complement serum globulin fraction in myasthenia gravis. Proc Soc Exp Biol Med 1960;105:184-191.
36. Limburg PC, The TH, Hummel-Tappel E, Oosterhuis HJGH. Anti-acetylcholine receptor antibodies in myasthenia gravis: I. Relation to clinical parameters in 250 patients. J Neurol Sci 1983;58:357-370.
37. Lopate G. Pestronk A. Autoimmune myasthenia gravis. Hosp Pract 1992;15:109-131.
38. Somnier FE. Clinical implementation of anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 1993:56:496-504.
39. Kennel PF, Poindron P, Warter JM, Forteneau P. Alpha-bungarotoxin sensitization in experimental autoimmune mynasthenia gravis. Muscle Nerve 1993;16:461-465.
40. Mozes E, Brocke S, Frieke H, Dayan M, Shoenfeld Y, Mendlovic S. New experimental autoimmune models. Jr J Med Sci 1989;25:692-695.
41. Tuma MFF. Miastenia grave induzida em animais por gamaglobulina de pacientes miastênicos: estudo clínico e eletrofisiologia em preparação neuromuscular Tese: Faculdade de Medicina da Universidade de São Paulo, São Paulo, 1990.
42. Niakan E, Haratti Y, Rolak LA. Immunosuppressive drug therapy in myasthenia gravis. Arch Neurol 1986;43:155-156.
43. Werneck LC, Moreira PM. Miastenia grave: tratamento clínico x cirúrgico. Arq Neuropsiquiatr 1991;49:409-417.
44. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci 1981;377:652-669.